PVAMC
PPS&V Asset Management Consultants Portfolio holdings
AUM
$159M
This Quarter Return
+9.71%
1 Year Return
+13.23%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
(+6.1%)
Cap. Flow
-$5.48M
Cap. Flow
% of AUM
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
85.67%
Holding
38
New
–
Increased
13
Reduced
16
Closed
–
Top Buys
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
$512K |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
$169K |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$116K |
| 4 |
Eli Lilly
LLY
|
$26.3K |
| 5 |
Vanguard Health Care ETF
VHT
|
$16.4K |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.68M |
| 2 |
Invesco QQQ Trust
QQQ
|
$1.05M |
| 3 |
Apple
AAPL
|
$768K |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
$723K |
| 5 |
Schwab US Large-Cap Growth ETF
SCHG
|
$697K |
Sector Composition
| 1 | Technology | 6.95% |
| 2 | Healthcare | 2.5% |
| 3 | Consumer Discretionary | 1.18% |
| 4 | Financials | 0.33% |
| 5 | Energy | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Badger Meter
BMI
$5.36B
| $472K | 0.38% |
3,200
| – | – |
|
27
WisdomTree US AI Enhanced Value Fund
AIVL
$392M
| $458K | 0.37% |
4,901
| – | – |
|
28
Johnson & Johnson
JNJ
$429B
| $449K | 0.36% |
2,715
+12
| +0.4% | +$1.99K |
|
|
29
Invesco S&P 500 Equal Weight ETF
RSP
$73.5B
| $413K | 0.33% |
3,840
+1,077
| +39% | +$116K |
|
30
Visa
V
$681B
| $402K | 0.33% |
1,693
-131
| -7% | -$31.1K |
|
31
Vanguard Information Technology ETF
VGT
$99.1B
| $384K | 0.31% |
868
| – | – |
|
32
Technology Select Sector SPDR Fund
XLK
$83.6B
| $352K | 0.29% |
2,025
+2
| +0.1% | +$348 |
|
33
iShares Morningstar Small-Cap ETF
ISCB
$246M
| $295K | 0.24% |
5,934
+14
| +0.2% | +$696 |
|
34
iShares Russell 2000 ETF
IWM
$66.6B
| $253K | 0.2% |
1,350
| – | – |
|
35
iShares Russell Mid-Cap Growth ETF
IWP
$20.3B
| $251K | 0.2% |
2,239
-360
| -14% | -$40.4K |
|
36
Marathon Petroleum
MPC
$54.4B
| $233K | 0.19% |
2,000
| – | – |
|
37
Freeport-McMoran
FCX
$66.3B
| $200K | 0.16% |
5,000
| – | – |
|
38
Outlook Therapeutics
OTLK
$39.5M
| $87.3K | 0.07% |
50,153
| – | – |
|